{"id":3689,"date":"2025-03-27T10:05:56","date_gmt":"2025-03-27T10:05:56","guid":{"rendered":"https:\/\/amoneta-diagnostics.com\/?p=3689"},"modified":"2025-11-24T02:42:16","modified_gmt":"2025-11-24T01:42:16","slug":"amoneta-diagnostics-at-ad-pd-2025","status":"publish","type":"post","link":"https:\/\/alzevit.com\/en\/amoneta-diagnostics-at-ad-pd-2025\/","title":{"rendered":"Amoneta Diagnostics at AD\/PD\u2122 2025: APO-Easy\u00ae Genotyping kit in the Context of New Therapies’ Launch"},"content":{"rendered":"

Amoneta Diagnostics is pleased to announce its\u2019 team\u2019s participation to the AD\/PD\u2122 2025 conference, a major international event that brings together experts in the field of Alzheimer\u2019s and Parkinson\u2019s disease.
\nThis year, the focus will be on APO-Easy\u00ae<\/a>, our CE-IVDR certified genotyping kit that is designed to assess genetic risk for Alzheimer\u2019s disease through the analysis of the APOE gene.
\nWith the launch of groundbreaking new treatments for Alzheimer\u2019s disease, the need for identifying patients who may benefit from such therapies has never been more urgent.<\/p>\n

Alzheimer\u2019s disease is a complex, multifactorial condition influenced by both genetic and environmental factors. Among the various genetic markers, the APOE gene (Apolipoprotein E) is one of the most significant, with three main variants: APOE \u03b52, APOE \u03b53, and APOE \u03b54. The APOE \u03b54 allele is linked to a higher risk of developing Alzheimer\u2019s disease, particularly in those who carry one or two copies of this allele.<\/p>\n

Leqembi and Kisunla are anti-amyloid treatments that are primarily beneficial for individuals with Alzheimer\u2019s who exhibit amyloid plaques. Their use should be carefully considered in those with the APOE \u03b54 allele due to an increased risk of side effects like ARIA (Amyloid-Related Imaging Abnormalities).
\nIn this process, APO-Easy\u00ae offers a simple, reliable way to detect the APOE \u03b54 allele. This non-invasive test not only provides insights into an individual\u2019s genetic predisposition but also helps determine eligibility for treatments.
\nBy identifying individuals at higher risk, the APO-Easy\u00ae genotyping kit helps guide treatment decisions and ensures that the right patients receive the right therapies at the right time, advancing precision medicine and improving quality of life for patients.<\/p>\n

We are excited to showcase APO-Easy\u00ae at AD\/PD\u2122 2025 and explore how this product, in conjunction with emerging therapies like Leqembi and Kisunla, is shaping the future of Alzheimer’s care.
\nWe invite you to visit our booth#27 to learn more about APO-Easy\u00ae<\/a> and our other diagnostic solutions<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Amoneta Diagnostics is pleased to announce its\u2019 team\u2019s participation to the AD\/PD\u2122 2025 conference, a major international event that brings together experts in the field of Alzheimer\u2019s and Parkinson\u2019s disease. This year, the focus will be on APO-Easy\u00ae, our CE-IVDR certified genotyping kit that is designed to assess genetic risk for Alzheimer\u2019s disease through the analysis of the APOE gene. With the launch of groundbreaking new treatments for Alzheimer\u2019s disease, the need for identifying patients who may benefit from such therapies has never been more urgent. Alzheimer\u2019s disease is a complex, multifactorial condition influenced by both genetic and environmental factors. Among the various genetic markers, the APOE gene (Apolipoprotein E) is one of the most significant, with three main variants: APOE \u03b52, APOE \u03b53, and APOE \u03b54. The APOE \u03b54 allele is linked to a higher risk of developing Alzheimer\u2019s disease, particularly in those who carry one or two copies of this allele. Leqembi and Kisunla are anti-amyloid treatments that are primarily beneficial for individuals with Alzheimer\u2019s who exhibit amyloid plaques. Their use should be carefully considered in those with the APOE \u03b54 allele due to an increased risk of side effects like ARIA (Amyloid-Related Imaging Abnormalities). In this process, APO-Easy\u00ae offers a simple, reliable way to detect the APOE \u03b54 allele. This non-invasive test not only provides insights into an individual\u2019s genetic predisposition but also helps determine eligibility for treatments. By identifying individuals at higher risk, the APO-Easy\u00ae genotyping kit helps guide treatment decisions and ensures that the right patients receive the right therapies at the right time, advancing precision medicine and improving quality of life for patients. We are excited to showcase APO-Easy\u00ae at AD\/PD\u2122 2025 and explore how this product, in conjunction with emerging therapies like Leqembi and Kisunla, is shaping the future of Alzheimer’s care. We invite you to visit our booth#27 to learn more about APO-Easy\u00ae and our other diagnostic solutions<\/p>","protected":false},"author":1,"featured_media":3691,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[80],"tags":[79,81,83],"class_list":["post-3689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events","tag-conference","tag-neurology","tag-products","cms-has-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/posts\/3689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/comments?post=3689"}],"version-history":[{"count":3,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/posts\/3689\/revisions"}],"predecessor-version":[{"id":4580,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/posts\/3689\/revisions\/4580"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/media\/3691"}],"wp:attachment":[{"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/media?parent=3689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/categories?post=3689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alzevit.com\/en\/wp-json\/wp\/v2\/tags?post=3689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}